Publications:

Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine.

Genes & Diseases

Guo, Chong C; Song, Chaoying C; Zhang, Jiali J; Gao, Yisong Y; Qi, Yuying Y; Zhao, Zongyao Z; Yuan, Chengfu C

Publication Date: 2022-05

Variant appearance in text: BRCA2: A2780R

PubMed Link: 35782973

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page

The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer.

Cancer Research

Patel, Monal M; Wang, Yinu Y; Bartom, Elizabeth T ET; Dhir, Rohin R; Nephew, Kenneth P KP; Matei, Daniela D; Murmann, Andrea E AE; Lengyel, Ernst E; Peter, Marcus E ME

Publication Date: 2021-08-01

Variant appearance in text: BRCA2: A2780R

PubMed Link: 34224372

Variant Present in the following documents:

• Main text
• 3985.pdf

View BVdb publication page

The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer.

Cancer Research

Patel, Monal M; Wang, Yinu Y; Bartom, Elizabeth T ET; Dhir, Rohin R; Nephew, Kenneth P KP; Matei, Daniela D; Murmann, Andrea E AE; Lengyel, Ernst E; Peter, Marcus E ME

Publication Date: 2021-08-01

Variant appearance in text: BRCA2: A2780R

PubMed Link: 34224372

Variant Present in the following documents:

• Main text
• 3985.pdf

View BVdb publication page

Potential application of curcumin and its analogues in the treatment strategy of patients with primary epithelial ovarian cancer.

International Journal Of Molecular Sciences

Terlikowska, Katarzyna M KM; Witkowska, Anna M AM; Zujko, Malgorzata E ME; Dobrzycka, Bozena B; Terlikowski, Slawomir J SJ

Publication Date: 2014-11-25

Variant appearance in text: BRCA2: A2780R

PubMed Link: 25429431

Variant Present in the following documents:

• Main text
• ijms-15-21703.pdf

View BVdb publication page